Latest News, Announcements, and Press Releases

  REDWOOD CITY, Calif. –(BUSINESS WIRE)–Sep. 26, 2019– Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, is contributing resources and expertise to communicate protein engineering’s vast potential at SynBioBeta’s Global Synthetic Biology Summit in San Francisco , Oct. 1–3.

REDWOOD CITY, Calif. , Sept. 26, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at the 2019 Cantor Fitzgerald Global Healthcare Conference on Friday, October 4 at 12:00 p.m. Eastern…

Product revenue up 68%; R&D revenue spread over wider base of customers and markets Conference call begins at 4:30 pm Eastern time today REDWOOD CITY, Calif. , Aug. 06, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein…

CFO Gordon Sangster announces retirement REDWOOD CITY, Calif. , Aug. 06, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces the appointment of Ross Taylor as Senior Vice President and Chief Financial Officer effective August…

REDWOOD CITY, Calif. , July 30, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report second quarter 2019 financial results after market close on Tuesday, August 6, 2019 . Codexis management…

Investment to fund strategic growth initiatives across the diverse and expanding synthetic biology end market REDWOOD CITY, Calif. , June 20, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading synthetic biology company, announces that Casdin Capital, LLC ,…

REDWOOD CITY, Calif. , May 30, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at the Jefferies 2019 Global Healthcare Conference on Thursday, June 6 at 2:30 p.m. Eastern time…

Third CodeEvolver® licensing agreement with a major pharma company REDWOOD CITY, Calif. , May 15, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces the signing of a CodeEvolver ® platform agreement with Novartis .

REDWOOD CITY, Calif. , May 14, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will participate in three upcoming investment conferences: UBS Global Healthcare Conference on May 21 at 8:00 a.m.

Total revenues increase 11% to $15.6 million , product revenue up 30% Recent highlights include Third CodeEvolver ® Platform Technology Agreement and Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for TASTEVA ® M Stevia Sweetener Conference call…